Equity Research firms currently have a positive stance on shares of Merck & Co., Inc. (NYSE:MRK). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.50. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $66.11 on a short term basis.
At the time of writing, the stock was trading at $62.18. This represents a change from the opening price of -0.48%. In terms of performance, year to date, the stock is 21.26%. The monthly stock performance comes in at 0.12%. For the quarter, shares are performing at 8.58%. Weekly performance analysis shows the equity at 0.60%.
In taking a look at technical levels, shares are trading 0.81% away from the 50 day simple moving average and 12.44% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -2.13% away from it’s 52- week high and 32.79% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Merck & Co., Inc.’s RSI stands at 47.52. In looking at volatility levels, the shares saw weekly volatility of 1.64% and 1.51% over the past month.